About IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
During the past decade, IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
According to Clinical.Site data, the most researched conditions in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are
"Aplastic Anemia" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Mantle Cell Lymphoma" (1 trials), "Myelodysplasia" (1 trials) and "Myelodysplastic-Myeloproliferative Diseases" (1 trials). Many other conditions were trialed in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" in a lesser frequency.
Clinical Trials Intervention Types at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
Most popular intervention types in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "BEAM" (1 trials), "Bendamustine, Lenalidomide, Rituximab" (1 trials), "Copanlisib" (1 trials) and "ZEVALIN" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
The vast majority of trials in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali" are
5 trials for "All" genders.
Clinical Trials Status at IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali
Currently, there are NaN active trials in "IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS-Centro di riferimento oncologico UO di ematologia e Trapianto Cellule Staminali, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".